Peter Repiščák
Impact in
-
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
-
- Prostate Cancer Treatment and Research
- Ferroptosis and cancer prognosis
Papers in
-
- Prostate Cancer Treatment and Research 8
-
- Cancer, Lipids, and Metabolism 4
- Co-authors
- Martin J. Paterson (4 shared papers)Stefan Erhardt (3 shared papers)Graham Rena (2 shared papers)Ian Galbraith (1 shared paper)Hing Y. Leung (5 shared papers)Rachana Patel (6 shared papers)Mark J. Salji (4 shared papers)Ernest J. Mui (4 shared papers)
- Journals
- EMBO Molecular Medicine (2 papers)Life Science Alliance (1 paper)Science Immunology (1 paper)Nature Communications (1 paper)Journal of Chemical Theory and Computation (1 paper)
- Partner nations
- United KingdomAustriaFinland
In The Last Decade
Peter Repiščák
19 papers receiving 691 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 109
- Pulmonary and Respiratory Medicine 186
- Aging 6
- Molecular Biology 199
- Physical and Theoretical Chemistry 25
Countries citing papers authored by Peter Repiščák
This map shows the geographic impact of Peter Repiščák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Repiščák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Repiščák more than expected).
Fields of papers citing papers by Peter Repiščák
This network shows the impact of papers produced by Peter Repiščák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Repiščák. The network helps show where Peter Repiščák may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Repiščák, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 148 | |
| 2 | 2017 | 126 | |
| 3 | 2016 | 102 | |
| 4 | 2016 | 51 | |
| 5 | 2014 | 46 | |
| 6 | 2019 | 39 | |
| 7 | 2021 | 32 | |
| 8 | 2018 | 25 | |
| 9 | 2021 | 25 | |
| 10 | 2022 | 25 | |
| 11 | 2020 | 17 | |
| 12 | 2020 | 16 | |
| 13 | 2019 | 11 | |
| 14 | 2022 | 11 | |
| 15 | 2023 | 9 | |
| 16 | 2022 | 7 | |
| 17 | Targeting cholesterol transport in castration-resistant prostate cancer | 2018 | 1 |
| 18 | 2024 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2026 | 0 |
About Peter Repiščák
Peter Repiščák is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Immunology, Atomic and Molecular Physics, and Optics and Physical and Theoretical Chemistry, having authored 20 papers that have together received 693 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (8 papers), Cancer, Lipids, and Metabolism (4 papers), Advanced Chemical Physics Studies (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Wnt/β-catenin signaling in development and cancer (1 paper), Trace Elements in Health (1 paper), Metal complexes synthesis and properties (1 paper) and Immune Cell Function and Interaction (1 paper). The work is most often cited by research in Cancer Research (109 citations), Pulmonary and Respiratory Medicine (186 citations), Aging (6 citations), Molecular Biology (199 citations) and Physical and Theoretical Chemistry (25 citations). Peter Repiščák has collaborated with scholars based in United Kingdom, Austria and Finland. Frequent co-authors include Martin J. Paterson, Stefan Erhardt, Graham Rena, Ian Galbraith, Hing Y. Leung, Rachana Patel, Mark J. Salji, Ernest J. Mui, Carolyn J. Loveridge and Imran Ahmad. Their work appears in journals such as EMBO Molecular Medicine, Life Science Alliance, Science Immunology, Nature Communications and Journal of Chemical Theory and Computation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.